ADC Therapeutics SA - Stock Price History | ADCT

Historical daily share price chart and data for ADC Therapeutics SA since 2022 adjusted for splits. The latest closing stock price for ADC Therapeutics SA as of December 02, 2022 is 3.62.
  • The all-time high ADC Therapeutics SA stock closing price was 51.05 on July 02, 2020.
  • The ADC Therapeutics SA 52-week high stock price is 22.52, which is 522.1% above the current share price.
  • The ADC Therapeutics SA 52-week low stock price is 3.31, which is 8.6% below the current share price.
  • The average ADC Therapeutics SA stock price for the last 52 weeks is 10.37.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
ADC Therapeutics SA Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 25.4419 32.2200 34.0500 19.2900 20.2000 -36.89%
2020 38.0118 29.6500 51.0500 25.2600 32.0100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.278B $0.034B
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $172.495B 10.52
GSK (GSK) United Kingdom $71.890B 9.01
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.433B 19.52
Ginkgo Bioworks Holdings (DNA) United States $3.861B 0.00
Myovant Sciences (MYOV) United Kingdom $2.605B 0.00
Arcus Biosciences (RCUS) United States $2.586B 38.81
Biohaven (BHVN) United States $1.141B 0.00
Emergent Biosolutions (EBS) United States $0.599B 4.71
Zymeworks (ZYME) Canada $0.478B 0.00
Enzo Biochem (ENZ) United States $0.096B 0.00
SQZ Biotechnologies (SQZ) United States $0.046B 0.00
Gelesis Holdings (GLS) United States $0.035B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00